Recent update from the regulatory landscape in clinical data management
Date: September 24, 2026
On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.
You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections
Scroll down to the Pre-inspection documentation tab to find the:
- GCP inspection dossier template – Computerised Systems
- GCP inspection dossier clinical trial spreadsheet – Computerised Systems
- GGP inspection dossier checklist – Computerised Systems.
MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.
An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.
For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:
- Number of substantial protocol amendments/modifications
- Number of change controls
- How many of these change controls related to a protocol amendment/modification
The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.
Explore More News
Regulatory Considerations DMEG reviews recent MHRA regulatory updates
The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .
Read More
ACDM26 Berlin: Shaping the Future of Clinical Data Management
The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .
Read More
Member News Update from Lab Data Solutions LLC
This news piece has been submitted by Lab Data Solutions LLC
We’re Attending US Summit . . .
Read More
Welcome Veramed as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .
Read More
Welcome CROss Alliance as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance . . .
Read More
Regulatory Considerations DMEG Update
With mixed feelings, we share that Silvia Pérez Torres, current chair of the ACDM . . .
Read More
Newsletter Committee’s Christmas Copilot Tips
In a time when we are constantly surrounded by artificial intelligence and feel the need . . .
Read More
Welcome Data Magik as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome Data Magik as . . .
Read More
Welcome The Institute of Cancer Research – Scientific Computing as a corporate member
The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .
Read More
Newsletter Committee: Meet Federica
The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .
Read More
Welcome P95 as a corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .
Read More
AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?
At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .
Read More
